Raffin Thomas A.'s Form 4 filing
Akoya Biosciences, Inc. (AKYA) · filed Jun 12, 2023
- Accession no.
- 0001104659-23-070479
- Filed
- Jun 12, 2023
- Trade date
- Jun 12, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $10.1M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Raffin Thomas A.CIK 0001512119 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2023 | Common Stock | PPurchaseAcquired | +20,000 | $5.00 | +$100,000 | 234,592 | Indirect | |
| Jun 12, 2023 | Common Stock | PPurchaseAcquired | +196,627 | $5.00 | +$983,135 | 1,737,712 | Indirect | |
| Jun 12, 2023 | Common Stock | PPurchaseAcquired | +1,803,373 | $5.00 | +$9,016,865 | 15,937,535 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.